U.S. markets closed

AgeX Therapeutics, Inc. (AGE)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
2.2500+0.0900 (+4.17%)
At close: 4:00PM EST

2.3800 +0.13 (5.78%)
After hours: 5:51PM EST

Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
Total Revenue
1,855
1,728
1,396
1,404
Cost of Revenue
215
244
364
168
Gross Profit
1,640
1,484
1,032
1,236
Operating Expense
14,272
14,043
12,277
9,653
Operating Income
-12,632
-12,559
-11,245
-8,417
Net Non Operating Interest Income Expense
-35
29
116
-12
Other Income Expense
347
294
3,398
1,792
Pretax Income
-12,320
-12,236
-7,731
-6,637
Tax Provision
75
148
-
-
Net Income Common Stockholders
-12,208
-12,154
-7,502
-6,580
Diluted NI Available to Com Stockholders
-12,208
-12,154
-7,502
-6,580
Basic EPS
-
0
0
0
Diluted EPS
-
0
0
0
Basic Average Shares
-
37,271
34,914
35,800
Diluted Average Shares
-
37,271
34,914
35,800
Total Operating Income as Reported
-12,632
-12,559
-11,245
-6,663
Total Expenses
14,487
14,287
12,641
9,821
Net Income from Continuing & Discontinued Operation
-12,208
-12,154
-7,502
-6,580
Normalized Income
-12,208
-12,154
-7,502
-8,334
Net Interest Income
-35
29
116
-12
EBIT
-12,632
-12,559
-11,245
-8,417
EBITDA
-11,463
-
-
-
Reconciled Cost of Revenue
215
244
364
168
Reconciled Depreciation
1,169
951
535
682
Net Income from Continuing Operation Net Minority Interest
-12,208
-12,154
-7,502
-6,580
Total Unusual Items Excluding Goodwill
-
-
0
1,754
Total Unusual Items
-
-
0
1,754
Normalized EBITDA
-11,463
-11,608
-10,710
-9,489
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0